影响溶解的因素：多晶型、无定形和假多晶型

Polymorphism refers to a drug substance existing in multiple crystalline forms with the same chemical formula but different structures and physical properties. Different polymorphs exhibit varying solubility rates; for example, chloramphenicol's highly soluble β-polymorph enhances drug absorption compared to less soluble forms. This variation directly impacts dissolution rates and bioavailability.

Metastable polymorphs can convert to more stable forms during manufacturing, causing tablet cracking or preventing granulation compression. These transitions occur because metastable forms possess higher free energy than stable polymorphs. Such changes may require product reformulation to maintain pharmaceutical quality and efficacy.

Solvates form when drugs interact with solvents during manufacturing. When water is the solvent, specific crystalline forms called hydrates are produced. These pseudopolymorphs possess different solubility characteristics than their anhydrous counterparts; for instance, erythromycin hydrates show distinct dissolution patterns compared to the anhydrate form.

Amorphous forms lack crystalline structures and dissolve more rapidly in aqueous solutions than crystalline forms. Being less structurally rigid, amorphous drugs often exhibit faster dissolution rates. However, some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, potentially leading to incomplete absorption.

The anhydrous form of ampicillin dissolves more quickly than ampicillin trihydrate, resulting in faster absorption. This difference stems from the distinct solubility characteristics of hydrated versus anhydrous forms. Faster dissolution of the anhydrous form enables more rapid drug availability for mechanisms of drug absorption paracellular transcellular and vesicular transport.

The most stable polymorph has the lowest free energy, making it thermodynamically favored. Metastable polymorphs possess higher free energy and may spontaneously transition to more stable forms over time. This energy difference explains why certain crystal forms persist during manufacturing while others convert, potentially causing formulation problems.

Erythromycin exists in dihydrate, monohydrate, and anhydrate forms, each displaying different solubility patterns. When percent dissolved is plotted against time, these hydrate forms show distinct dissolution curves. The variation in water content directly influences the crystal structure and aqueous solubility of each form.